NCI at ASCO 2020
Sunday, May 31
Thank you for joining us during the ASCO Virtual Scientific Program. If you haven't had a chance to register yet, there's still time to join for today's sessions and to watch content on-demand.
In Case You Missed It: View Dr. Sharpless' Presentation On-Demand
Ensuring Cancer Research Progress During a Global Pandemic
NCI Director Dr. Sharpless discussed the impact of COVID-19 on cancer care and research, including the decrease in the accrual to clinical trials. He also addressed how NCI plans to move forward to ensure cancer research progress, how the cancer community has already stepped up, and ways that NCI has responded to COVID-19 including modifications to the clinical trial processes, a Tocilizumab compassionate use study, and a national COVID-19 natural history study.
View his presentation on-demand.
|
Don't Miss Out: NCCAPS Presentation in June
We invite you to join us in June for an informational presentation. Click here to be notified of this future session.
NCI recently launched a national, longitudinal study of COVID-19 in people with cancer. The NCI COVID-19 in Cancer Patients Study (NCCAPS) will help scientists answer key questions about COVID-19’s impact on cancer patients, as well as cancer’s impact on the course of COVID-19.
We also encourage you to learn more in a recent Cancer Currents blog post by NCI Deputy Director, Dr. James H. Doroshow, "How Does COVID-19 Affect People with Cancer? NCCAPS Will Help Find Out"
|
Connect with NCI at ASCO
Visit our NCI at ASCO page to learn more about NCI presentations available on-demand, funding opportunities, and resources available.
Have questions you need answered from the NCI? Find us in the virtual exhibit hall, which is open through August.
Couldn't Attend? Join us at the ASCO Virtual Education Program
We're sorry we missed you! You can watch archived presentations from the ASCO Virtual Scientific Program on-demand. You must register to view on-demand content.
Registration also provides access to the ASCO Virtual Education Program, Aug. 8-10. We hope to see you there!
No hay comentarios:
Publicar un comentario